FDA approves MiniMed 530G System for Diabetic patients
The FDA has given marketing approval for the MiniMed 530G, from Medtronic. The device has Enlite, a Threshold Suspend automation system and is indicated for people over 18 with Diabetes. The MiniMed 530G system incorporates the new Enlite sensor, Medtronic's most accurate and comfortable continuous glucose sensor with a 31 percent improvement in overall accuracy from the previous generation.
The Enlite sensor detects up to 93 percent of hypoglycemia episodes when predictive and threshold alerts are on. Medtronic will conduct a post-approval study including children ages two and older.
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.